M Hogardt Selected Research

Tobramycin (Nebcin)

1/2006

Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Hogardt Research Topics

Disease

4	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2006
1	Healthcare-Associated Pneumonia 10/2022
1	Infections 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 10/2022
1	Lung Diseases (Lung Disease) 01/2014
1	Diphtheria 10/2010
1	Otitis Media 11/2009
1	Lymphadenopathy 11/2009
1	Diverticulitis 12/2008
1	Abdominal Pain (Pain, Abdominal) 12/2008
1	Abscess 12/2008

Drug/Important Bio-Agent (IBA)

1	carbapenemaseIBA 10/2022
1	tazobactam drug combination ceftolozaneIBA 10/2022
1	ceftazidime drug combination avibactamIBA 10/2022
1	CefiderocolIBA 10/2022
1	AzolesIBA 01/2018
1	Insulin (Novolin)FDA Link 12/2008
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2006
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2006
1	Meropenem (Merrem)FDA LinkGeneric 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006
1	Drug CombinationsIBA 01/2006

Therapy/Procedure

2	Lung Transplantation 01/2015 - 01/2014
1	Lasers (Laser) 10/2010
1	Therapeutics 11/2009
1	Drug Therapy (Chemotherapy) 12/2008